CAS 14899-36-6
:Dexamethasonpalmitat
- (11Beta,16Alpha)-9-Fluoro-11,17-Dihydroxy-16-Methyl-3,20-Dioxopregna-1,4-Dien-21-Yl Hexadecanoate
- (11β,16α)-9-Fluoro-11,17-dihydroxy-16-methyl-21-[(1-oxohexadecyl)oxy]pregna-1,4-diene-3,20-dione
- DXM-21-palmitate
- Dexamethasone-21-palmitate
- Limethason
- Limethasone
- Lipotalon
- Palmitic acid, 21-ester with 9-fluoro-11β,17,21-trihydroxy-16α-methylpregna-1,4-diene-3,20-dione
- Pregna-1,4-diene-3,20-dione, 9-fluoro-11,17-dihydroxy-16-methyl-21-[(1-oxohexadecyl)oxy]-, (11β,16α)-
- Pregna-1,4-diene-3,20-dione, 9-fluoro-11β,17,21-trihydroxy-16α-methyl-, 21-palmitate
Dexamethasone palmitate
CAS:Formel:C38H59FO6Reinheit:99%Farbe und Form:SolidMolekulargewicht:630.8699Dexamethasone 21-Palmitate
CAS:Kontrolliertes ProduktApplications A corticosteroid prodrug for the treatment of eye disorders.
References Benameur, H., et al.: J. Pharm. Pharmacol., 47, 812 (1995), Tauchi, Y., et al.: Biol. Pharm. Bull., 24, 925 (2001), Chono, S., et al.: J. Drug Targeting, 13, 407 (2005),Formel:C38H59FO6Farbe und Form:NeatMolekulargewicht:630.87Dexamethasone 21-Palmitate-d31
CAS:Kontrolliertes ProduktApplications A labelled orticosteroid prodrug for the treatment of eye disorders.
References Benameur, H., et al.: J. Pharm. Pharmacol., 47, 812 (1995), Tauchi, Y., et al.: Biol. Pharm. Bull., 24, 925 (2001), Chono, S., et al.: J. Drug Targeting, 13, 407 (2005),Formel:C38D31H28FO6Farbe und Form:NeatMolekulargewicht:662.06Dexamethasone palmitate
CAS:DXP, a lipophilic prodrug of Dexamethasone, has 47x less glucocorticoid receptor affinity; it's an agonist & anti-inflammatory.Formel:C38H59FO6Reinheit:99.28%Farbe und Form:SolidMolekulargewicht:630.87Dexamethasone 21-palmitate
CAS:Kontrolliertes ProduktDexamethasone 21-palmitate is a sample preparation agent that is used to prevent the loss of cells or particles during storage. It can be used in vitro as an immunosuppressant to inhibit lymphocyte transformation, particle, and cell nuclei formation. Dexamethasone 21-palmitate is also used for eye disorders, inflammatory bowel disease, and human macrophages. The product may also be used for choroidal neovascularization in eye disorders.
Formel:C38H59FO6Reinheit:Min. 95%Farbe und Form:White PowderMolekulargewicht:630.87 g/molRef: 3D-FD21400
Ausgelaufenes produkt





